Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])

• Status: Terminated
• Trial end date: 2012-05-01

Summary

Sponsor has decided to discontinue Luveris® in the United States (US) due to level of customer demand for this product, and not due to any efficacy or safety concerns.

• Phase: Phase 4

Details

• Lead Sponsor: EMD Serono
• Treatments: Chorionic Gonadotropin; Follicle Stimulating Hormone; Hormones